The rationale and recommendations for use for newly licensed vaccines will be reviewed to include the new meningococcal conjugate vaccines and the new tetinus-diphtheria-acellular pertussis vaccine for adolescents.  Also, vaccines with anticipated FDA approval will be discussed.

      Educational Objectives:

• Recognize the value of and reasoning behind endorsement of use of meningococcal conjugate vaccines.
• Define the need for pertussis booster vaccinations of adolescents & adults in the U.S.
• Know the national recommendations regarding use of meningococcal & pertussis vaccines in the U.S.
• Identify risk factors in acquiring HPV infection
  

• Exciting update of newly licensed vaccines
• Overview of vaccines on the horizon
• Interactive Audience Response System
• Presented and developed by nationally recognized opinion leaders

back to top

Michael E. Pichichero, MD
Director
Rochester General Research Institute
and Legacy Pediatrics
Rochester, NY

*You will need the free Adobe Acrobat Reader to view the Brochure.
Click here to download.